論文

査読有り
2019年7月

PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Reinmuth N
    • ,
  • Bryl M
    • ,
  • Bondarenko I
    • ,
  • Syrigos K
    • ,
  • Vladimirov V
    • ,
  • Zereu M
    • ,
  • Bair AH
    • ,
  • Hilton F
    • ,
  • Liau K
    • ,
  • Kasahara K
DOI
10.1007/s40259-019-00363-4
リンク情報
DOI
https://doi.org/10.1007/s40259-019-00363-4
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31338773
ID情報
  • DOI : 10.1007/s40259-019-00363-4
  • ISSN : 1173-8804
  • PubMed ID : 31338773
エクスポート
BibTeX RIS
論文リストへ